These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3097410

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The experience of neonatal screening for congenital adrenal hyperplasia.
    Cicognani A.
    Horm Res; 1992; 37 Suppl 3():34-8. PubMed ID: 1427639
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical significance of serum 17 alpha-hydroxyprogesterone analysis in endocrine tests of the adrenal cortex].
    Watanabe F.
    Nihon Rinsho; 1989 Dec; 48 Suppl():1231-4. PubMed ID: 2621850
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots.
    Larsson A, Hagenfeldt L, von Döbeln U, Curstedt T, Gustafsson J, Svensson E.
    Horm Res; 1988 Dec; 30(6):235-40. PubMed ID: 3250925
    [Abstract] [Full Text] [Related]

  • 6. Neonatal screening for congenital adrenal hyperplasia: a pilot study in France.
    Dhondt JL, Dorche C, Farriaux JP, Courte C.
    J Inherit Metab Dis; 1986 Dec; 9 Suppl 1():147-51. PubMed ID: 3097414
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 11. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 2. Analysis of steroids with high-performance liquid chromatography for diagnosis of congenital adrenal hyperplasia].
    Mizushima Y, Fukushi M, Arai O, Takasugi N, Fujieda K, Matsuura N, Fujimoto S.
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb 20; 63(2):102-12. PubMed ID: 3494637
    [Abstract] [Full Text] [Related]

  • 12. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
    Thil'en A, Nordenström A, Hagenfeldt L, von Döbeln U, Guthenberg C, Larsson A.
    Pediatrics; 1998 Apr 20; 101(4):E11. PubMed ID: 9521977
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Screening for late-onset congenital adrenal hyperplasia in hirsutism or amenorrhea.
    Baskin HJ.
    Arch Intern Med; 1987 May 20; 147(5):847-8. PubMed ID: 3579438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.
    Hubl W, Fehér T, Rohde W, Dörner G, Taubert H, Freymann E.
    Endokrinologie; 1982 Jun 20; 79(2):165-72. PubMed ID: 6751805
    [Abstract] [Full Text] [Related]

  • 17. [Clinical variants of virile form of congenital adrenocortical dysfunction].
    Dzenis IG, Latypova NKh, Kuznetsova MN.
    Akush Ginekol (Mosk); 1990 Apr 20; (4):25-8. PubMed ID: 2165743
    [No Abstract] [Full Text] [Related]

  • 18. [Fluorescent enzyme immunoassay for 17 alpha-hydroxyprogesterone].
    Ikegami T, Maeda M, Tsuji A, Hosoda H, Nambara T.
    Yakugaku Zasshi; 1987 Feb 20; 107(2):150-6. PubMed ID: 3298613
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.